Related Experiment Videos
p53 expression in dedifferentiated chondrosarcoma
W W Simms1, N G Ordóñez, D Johnston
1Department of Pathology, University of Texas, M.D. Anderson Cancer Center, Houston 77030, USA.
Background:
p53 acts as a tumor suppressor gene because of to its negative control of the cell cycle and its central role in programmed cell death. It frequently is mutated, as observed in a variety of human neoplasms. The mutations inhibit tumor-suppressor activities of p53, which may gain a new function of tumor promotion. In this study, p53 was investigated in various components of dedifferentiated chondrosarcoma and correlated with their proliferative activities.
Methods:
Immunohistochemical assays for p53, Ki-67, and proliferating cell nuclear antigen (PCNA) were used in a series of eight dedifferentiated chondrosarcomas of bone. The cartilaginous component was low grade (Grade I-II) in five cases. It was predominantly low grade with foci of a high grade (Grade III) chondrosarcoma in the remaining three cases. The noncartilaginous (dedifferentiated) high grade component consisted of malignant fibrous histiocytoma in five cases and osteosarcoma in three.
Results:
Regardless of the histological type, diffuse strong nuclear staining for p53 occurred in the high grade noncartilaginous component of all eight of the tumors. The low grade cartilaginous component of six cases was negative for p53, with focal weak staining in the two remaining cases. The high grade cartilaginous component showed strong positive staining for this protein in all three cases. Ki-67 and PCNA expression were similar to that of p53.
Conclusions:
The percentage of p53 positive staining roughly was parallel to the proliferating fraction of cells in various components of dedifferentiated chondrosarcoma. Moreover, p53 overexpression was consistently present in the high grade noncartilaginous (dedifferentiated) component of the tumor and was accompanied by increased proliferative activity.
Insights
p53 protein overexpression correlates with increased cell proliferation in dedifferentiated chondrosarcoma. This finding highlights p53
Area of Science:
- Oncology
- Molecular Biology
- Pathology
Background:
- p53 functions as a tumor suppressor by regulating cell cycle and apoptosis.
- Mutations in p53 can lead to loss of tumor suppression and potential tumor promotion.
- Dedifferentiated chondrosarcoma is a bone neoplasm with distinct histological components.
Purpose of the Study:
- To investigate p53 expression in different components of dedifferentiated chondrosarcoma.
- To correlate p53 levels with cellular proliferative activity in these tumors.
Main Methods:
- Immunohistochemical analysis of p53, Ki-67, and PCNA in eight dedifferentiated chondrosarcomas.
- Assessment of both cartilaginous and noncartilaginous tumor components.
- Categorization of tumor grades (I-III) and histological subtypes.
Main Results:
- Strong p53 nuclear staining was observed in the high-grade noncartilaginous component of all tumors.
- Low-grade cartilaginous areas showed minimal to no p53 staining.
- High-grade cartilaginous areas exhibited strong p53 positivity.
- Ki-67 and PCNA expression patterns mirrored p53 staining.
Conclusions:
- p53 positive staining intensity correlates with the proliferative fraction in dedifferentiated chondrosarcoma.
- p53 overexpression is a consistent feature of the high-grade, dedifferentiated tumor component.
- Increased proliferative activity is associated with p53 overexpression in this tumor type.